Page 247 - எங்களுக்கு தேசிய நிறுவனங்கள் ஆஃப் ஆரோக்கியம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Story highlights The South African variant is considered among the more dangerous of current mutations because it evades some of the blocking action of antibodies that target the older coronavirus strain. Pfizer and BioNTech have been studying adding a third dose to their vaccine regime and testing a new version that will target the South African variant of the coronavirus. The South African variant is considered among the more dangerous of current mutations because it evades some of the blocking action of antibodies that target the older coronavirus strain. Concerns have since risen that more transmissible variants such as the one first detected in South Africa or another in Britain are more resistant to existing vaccines.

South africaUnited statesUnited kingdomSouth africanUs national institutes of healthஒன்றுபட்டது மாநிலங்களில்ஒன்றுபட்டது கிஂக்டம்எங்களுக்கு தேசிய நிறுவனங்கள் ஆஃப் ஆரோக்கியம்